View in EDS

Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.

Saved in:
Bibliographic Details
Title: Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Authors: de Mooij CM; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., Simons JM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Amstel FJG; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. Electronic address: florien.vanamstel@maastrichtuniversity.nl., Mitea C; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany., van der Pol CC; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands., Luiten EJT; Department of Surgery, Amphia Hospital Breda, Breda, the Netherlands; Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi Emirate, Al Ain, United Arab Emirates., Koppert LB; Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Corporate Authors: REFINE Study Group
Source: Breast (Edinburgh, Scotland) [Breast] 2026 Apr; Vol. 86, pp. 104718. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41655532
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of axillary disease extent defined by baseline <superscript>18</superscript>F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Mooij+CM%22">de Mooij CM</searchLink>; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Simons+JM%22">Simons JM</searchLink>; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Amstel+FJG%22">van Amstel FJG</searchLink>; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. Electronic address: florien.vanamstel@maastrichtuniversity.nl.<br /><searchLink fieldCode="AU" term="%22Mitea+C%22">Mitea C</searchLink>; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Diest+PJ%22">van Diest PJ</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nelemans+PJ%22">Nelemans PJ</searchLink>; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mottaghy+FM%22">Mottaghy FM</searchLink>; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22van+der+Pol+CC%22">van der Pol CC</searchLink>; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Luiten+EJT%22">Luiten EJT</searchLink>; Department of Surgery, Amphia Hospital Breda, Breda, the Netherlands; Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi Emirate, Al Ain, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Koppert+LB%22">Koppert LB</searchLink>; Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Smidt+ML%22">Smidt ML</searchLink>; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Nijnatten+TJA%22">van Nijnatten TJA</searchLink>; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22REFINE+Study+Group%22">REFINE Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229213011%22">Breast (Edinburgh, Scotland)</searchLink> [Breast] 2026 Apr; Vol. 86, pp. 104718. <i>Date of Electronic Publication: </i>2026 Jan 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9213011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-3080 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209609776%22">09609776 </searchLink><i>NLM ISO Abbreviation: </i>Breast <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41655532
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.breast.2026.104718
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104718
    Titles:
      – TitleFull: Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Mooij CM
      – PersonEntity:
          Name:
            NameFull: Simons JM
      – PersonEntity:
          Name:
            NameFull: van Amstel FJG
      – PersonEntity:
          Name:
            NameFull: Mitea C
      – PersonEntity:
          Name:
            NameFull: van Diest PJ
      – PersonEntity:
          Name:
            NameFull: Nelemans PJ
      – PersonEntity:
          Name:
            NameFull: Mottaghy FM
      – PersonEntity:
          Name:
            NameFull: van der Pol CC
      – PersonEntity:
          Name:
            NameFull: Luiten EJT
      – PersonEntity:
          Name:
            NameFull: Koppert LB
      – PersonEntity:
          Name:
            NameFull: Smidt ML
      – PersonEntity:
          Name:
            NameFull: van Nijnatten TJA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-3080
          Numbering:
            – Type: volume
              Value: 86
          Titles:
            – TitleFull: Breast (Edinburgh, Scotland)
              Type: main
ResultId 1